Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use.
Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.|Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Lucas L
LL
van den Hoogen
Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.|1st Medical Department Hanusch Hospital, Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, Vienna, Austria.|Sigmund Freud University, Vienna, Austria.
Ruth D E
RD
Fritsch-Stork
Department of Immunology, Erasmus Medical Centre, Rotterdam, The Netherlands.
Marjan A
MA
Versnel
Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Ronald H Wm
RH
Derksen
Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.|Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Joël A G
JA
van Roon
Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.|Department of Rheumatology and Clinical Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Timothy R Dj
TR
Radstake
D016736:Antiphospholipid Syndrome; D006801:Humans; D006886:Hydroxychloroquine; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007370:Interferon Type I; D008180:Lupus Erythematosus, Systemic; D009000:Monocytes
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007370:Interferon Type I; D006886:Hydroxychloroquine
Antiphospholipid Syndrome; Autoimmune Diseases; Cytokines; Inflammation; Systemic Lupus Erythematosus